3 Year Absolute Returns
77.54% ↑
NAV (₹) on 15 Sep 2026
46.00
1 Day NAV Change
-0.97%
Risk Level
Very High Risk
Rating
-
ICICI Prudential Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ICICI Prudential Asset Management Co. Ltd.. Launched on 25 Jun 2018, investors can start ... Read more
AUM
₹ 6,995.62 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 78.39% |
| Hospitals & Medical Services | 10.70% |
| Treps/Reverse Repo | 4.78% |
| Services - Others | 1.92% |
| Chemicals - Organic - Others | 1.22% |
| Insurance Distributor | 1.13% |
| Chemicals - Speciality | 0.97% |
| Medical Equipment & Accessories | 0.67% |
| Current Assets | 0.20% |
| Cash | 0.01% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.31% | ₹ 861.02 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 8.26% | ₹ 578.12 | Pharmaceuticals |
| Cipla Ltd. | 5.76% | ₹ 402.74 | Pharmaceuticals |
| Mankind Pharma Ltd. | 5.21% | ₹ 364.60 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 4.87% | ₹ 340.98 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 4.83% | ₹ 337.57 | Pharmaceuticals |
| TREPS | 4.78% | ₹ 334.29 | Others |
| Biocon Ltd. | 4.68% | ₹ 327.26 | Pharmaceuticals |
| Medplus Health Services Ltd | 4.15% | ₹ 290.26 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 4.08% | ₹ 285.73 | Pharmaceuticals |
| Syngene International Ltd. | 3.29% | ₹ 230.35 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd | 2.79% | ₹ 195.02 | Hospitals & Medical Services |
| MAX Healthcare Institute Ltd | 2.59% | ₹ 181.47 | Hospitals & Medical Services |
| Alembic Pharmaceuticals Ltd. | 2.48% | ₹ 173.45 | Pharmaceuticals |
| Abbott India Ltd. | 2.38% | ₹ 166.37 | Pharmaceuticals |
| Akums Drugs and Pharmaceuticals Ltd. | 1.99% | ₹ 139.48 | Pharmaceuticals |
| Astrazeneca Pharma India Ltd. | 1.99% | ₹ 138.86 | Pharmaceuticals |
| Lupin Ltd. | 1.96% | ₹ 137.20 | Pharmaceuticals |
| Blue Jet Healthcare Ltd. | 1.93% | ₹ 135.26 | Pharmaceuticals |
| Indegene Ltd. | 1.92% | ₹ 134.03 | Services - Others |
| Pfizer Ltd. | 1.86% | ₹ 129.99 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 1.74% | ₹ 121.82 | Hospitals & Medical Services |
| Rainbow Childrens Medicare Ltd | 1.36% | ₹ 95.32 | Hospitals & Medical Services |
| Thyrocare Technologies Ltd. | 1.30% | ₹ 90.72 | Hospitals & Medical Services |
| Entero Healthcare Solutions | 1.23% | ₹ 86.24 | Pharmaceuticals |
| Fine Organic Industries Ltd. | 1.22% | ₹ 85.42 | Chemicals - Organic - Others |
| Alivus Life Sciences Ltd. | 1.21% | ₹ 84.68 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.13% | ₹ 79.26 | Insurance Distributor |
| Aarti Drugs Ltd. | 1.10% | ₹ 76.79 | Pharmaceuticals |
| Hikal Ltd. | 1.05% | ₹ 73.34 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd | 0.97% | ₹ 68.12 | Chemicals - Speciality |
| Manipal Health Enterprises Ltd. | 0.92% | ₹ 64.57 | Hospitals & Medical Services |
| Laxmi Dental Ltd. | 0.67% | ₹ 46.84 | Medical Equipment & Accessories |
| FDC Ltd. | 0.62% | ₹ 43.22 | Pharmaceuticals |
| Indoco Remedies Ltd. | 0.58% | ₹ 40.44 | Pharmaceuticals |
| Windlas Biotech Ltd. | 0.57% | ₹ 40.17 | Pharmaceuticals |
| Net Current Assets | 0.20% | ₹ 14.21 | Others |
| Cash Margin - Derivatives | 0.01% | ₹ 0.41 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 6.51% | 5.31% | 4.67% | 21.09% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
What is the current NAV of ICICI Prudential Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of ICICI Prudential Healthcare Fund - Direct Plan Growth?
What are the historical returns of ICICI Prudential Healthcare Fund - Direct Plan Growth?
What is the risk level of ICICI Prudential Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for ICICI Prudential Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article